Glia, sympathetic activity and cardiovascular disease

Experimental Physiology

Volumn 101, Issue 5, 2016, Pages 565-576

  Marina, Nephtali ^a   Teschemacher, Anja G ^b   Kasparov, Sergey ^b   Gourine, Alexander V ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; CALCIUM ION; DEXTRO SERINE; G PROTEIN COUPLED RECEPTOR; GLUTAMIC ACID; LACTIC ACID; METABOTROPIC RECEPTOR 5; TUMOR NECROSIS FACTOR;

ARTERIAL PRESSURE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; BRAIN HYPOXIA; BRAIN STEM; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM; CHEMOSENSITIVITY; CHRONIC INFLAMMATION; CHRONIC INTERMITTENT HYPOXIA; ESSENTIAL HYPERTENSION; GLIA; GLIA CELL; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERCAPNIA; HYPERTENSION; HYPOTHALAMUS; INFLAMMATION; MACROPHAGE ACTIVATION; MENTAL DISEASE; MICROGLIA; NERVE CELL NETWORK; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; OPTOGENETICS; PATHOGENESIS; PATHOPHYSIOLOGY; ROSTRAL VENTROLATERAL MEDULLA; SYMPATHETIC TONE; ADRENERGIC SYSTEM; ANIMAL; HYPOXIA; MEDULLA OBLONGATA; NERVE CELL; PHYSIOLOGY;

ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; HYPOXIA; MEDULLA OBLONGATA; NEUROGLIA; NEURONS; SYMPATHETIC NERVOUS SYSTEM;

EID: 84963865545     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/EP085713     Document Type: Article

References (99)

1. 2+ signaling. Science 327, 1250-1254.
2. Andjelkovic AV, Kerkovich D & Pachter JS (2000). Monocyte:astrocyte interactions regulate MCP-1 expression in both cell types. J Leukoc Biol 68, 545-552.
3. Angelova PR, Kasymov V, Christie I, Sheikhbahaei S, Turovsky E, Marina N, Korsak A, Zwicker J, Teschemacher AG, Ackland GL, Funk GD, Kasparov S, Abramov AY & Gourine AV (2015). Functional oxygen sensitivity of astrocytes. J Neurosci 35, 10460-10473.
4. Asano T, Mori T, Shimoda T, Shinagawa R, Satoh S, Yada N, Katsumata S, Matsuda S, Kagamiishi Y & Tateishi N (2005). Arundic acid (ONO-2506) ameliorates delayed ischemic brain damage by preventing astrocytic overproduction of S100B. Curr Drug Targets CNS Neurol Disord 4, 127-142.
5. Badoer E (2010). Microglia: activation in acute and chronic inflammatory states and in response to cardiovascular dysfunction. Int J Biochem Cell Biol 42, 1580-1585.
6. Bevan RD (1984). Trophic effects of peripheral adrenergic nerves on vascular structure. Hypertension 6, III19-III26.
7. Bezzi P, Domercq M, Brambilla L, Galli R, Schols D, De Clercq E, Vescovi A, Bagetta G, Kollias G, Meldolesi J & Volterra A (2001). CXCR4-activated astrocyte glutamate release via TNFα: amplification by microglia triggers neurotoxicity. Nat Neurosci 4, 702-710.
8. Boutouyrie P, Lacolley P, Girerd X, Beck L, Safar M & Laurent S (1994). Sympathetic activation decreases medium-sized arterial compliance in humans. Am J Physiol Heart Circ Physiol 267, H1368-H1376.
9. Bradley TD & Floras JS (2003a). Sleep apnea and heart failure: Part I: obstructive sleep apnea. Circulation 107, 1671-1678.
10. Bradley TD & Floras JS (2003b). Sleep apnea and heart failure: Part II: central sleep apnea. Circulation 107, 1822-1826.
11. Bramham CR, Torp R, Zhang N, Storm-Mathisen J & Ottersen OP (1990). Distribution of glutamate-like immunoreactivity in excitatory hippocampal pathways: a semiquantitative electron microscopic study in rats. Neuroscience 39, 405-417.
12. Burnstock G (2007). Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 87, 659-797.
13. Carlyle M, Jones OB, Kuo JJ & Hall JE (2002). Chronic cardiovascular and renal actions of leptin: role of adrenergic activity. Hypertension 39, 496-501.
14. Cates MJ, Dickinson CJ, Hart ECJ & Paton JFR (2012). Neurogenic hypertension and elevated vertebrobasilar arterial resistance: is there a causative link? Curr Hypertens Rep 14, 261-269.
15. Cates MJ, Steed PW, Abdala AP, Langton PD & Paton JFR (2011). Elevated vertebrobasilar artery resistance in neonatal spontaneously hypertensive rats. J Appl Physiol 111, 149-156.
16. Cotrina ML, Lin JH, Lopez-Garcia JC, Naus CC & Nedergaard M (2000). ATP-mediated glia signaling. J Neurosci 20, 2835-2844.
17. Dampney RA (1994). The subretrofacial vasomotor nucleus: anatomical, chemical and pharmacological properties and role in cardiovascular regulation. Prog Neurobiol 42, 197-227.
18. Dampney RA, Horiuchi J, Tagawa T, Fontes MA, Potts PD & Polson JW (2003). Medullary and supramedullary mechanisms regulating sympathetic vasomotor tone. Acta Physiol Scand 177, 209-218.
19. Derecki NC, Cronk JC, Lu Z, Xu E, Abbott SB, Guyenet PG & Kipnis J (2012). Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature 484, 105-109.
20. Domercq M, Brambilla L, Pilati E, Marchaland J, Volterra A & Bezzi P (2006). P2Y1 receptor-evoked glutamate exocytosis from astrocytes: control by tumor necrosis factor-α and prostaglandins. J Biol Chem 281, 30684-30696.
21. Esler M & Kaye D (2000). Measurement of sympathetic nervous system activity in heart failure: the role of norepinephrine kinetics. Heart Fail Rev 5, 17-25.
22. Esler M, Lambert G & Jennings G (1989). Regional norepinephrine turnover in human hypertension. Clin Exp Hypertens A 11 Suppl 1, 75-89.
23. Esler M, Rumantir M, Kaye D, Jennings G, Hastings J, Socratous F & Lambert G (2001). Sympathetic nerve biology in essential hypertension. Clin Exp Pharmacol Physiol 28, 986-989.
24. Fiacco TA, Agulhon C, Taves SR, Petravicz J, Casper KB, Dong X, Chen J & McCarthy KD (2007). Selective stimulation of astrocyte calcium in situ does not affect neuronal excitatory synaptic activity. Neuron 54, 611-626.
25. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D & Turner MB (2013). Executive summary: heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 127, 143-152.
26. Gourine AV, Kasymov V, Marina N, Tang F, Figueiredo MF, Lane S, Teschemacher AG, Spyer KM, Deisseroth K & Kasparov S (2010). Astrocytes control breathing through pH-dependent release of ATP. Science 329, 571-575.
27. Gourine AV, Llaudet E, Dale N & Spyer KM (2005a). ATP is a mediator of chemosensory transduction in the central nervous system. Nature 436, 108-111.
28. Gourine AV, Llaudet E, Dale N & Spyer KM (2005b). Release of ATP in the ventral medulla during hypoxia in rats: role in hypoxic ventilatory response. J Neurosci 25, 1211-1218.
29. Gourine AV, Wood JD & Burnstock G (2009). Purinergic signalling in autonomic control. Trends Neurosci 32, 241-248.
30. Grassi G (2009). Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives. Hypertension 54, 690-697.
31. Grassi G, Colombo M, Seravalle G, Spaziani D & Mancia G (1998). Dissociation between muscle and skin sympathetic nerve activity in essential hypertension, obesity, and congestive heart failure. Hypertension 31, 64-67.
32. Grassi G, Dell'Oro R, Seravalle G, Foglia G, Trevano FQ & Mancia G (2002). Short- and long-term neuroadrenergic effects of moderate dietary sodium restriction in essential hypertension. Circulation 106, 1957-1961.
33. Grassi G, Giannattasio C, Cleroux J, Cuspidi C, Sampieri L, Bolla GB & Mancia G (1988). Cardiopulmonary reflex before and after regression of left ventricular hypertrophy in essential hypertension. Hypertension 12, 227-237.
34. Guyenet PG (2000). Neural structures that mediate sympathoexcitation during hypoxia. Respir Physiol 121, 147-162.
35. Guyenet PG, Stornetta RL, Bochorishvili G, Depuy SD, Burke PG & Abbott SB (2013). C1 neurons: the body's EMTs (2013). Am J Physiol Regul Integr Comp Physiol 305, 187-204.
36. Halassa MM, Fellin T & Haydon PG (2009). Tripartite synapses: roles for astrocytic purines in the control of synaptic physiology and behavior. Neuropharmacology 57, 343-346.
37. Halassa MM, Fellin T, Takano H, Dong JH & Haydon PG (2007). Synaptic islands defined by the territory of a single astrocyte. J Neurosci 27, 6473-6477.
38. Hamilton NB & Attwell D (2010). Do astrocytes really exocytose neurotransmitters? Nat Rev Neurosci 11, 227-238.
39. Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA & Korner PI (1986). Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 73, 615-621.
40. Higashino H, Niwa A, Satou T, Ohta Y, Hashimoto S, Tabuchi M & Ooshima K (2009). Immunohistochemical analysis of brain lesions using S100B and glial fibrillary acidic protein antibodies in arundic acid- (ONO-2506) treated stroke-prone spontaneously hypertensive rats. J Neural Transm 116, 1209-1219.
41. Holmström KM, Marina N, Baev AY, Wood NW, Gourine AV & Abramov AY (2013). Signalling properties of inorganic polyphosphate in the mammalian brain. Nat Commun 4, 1362.
42. Horiuchi J, Potts PD, Tagawa T & Dampney RA (1999). Effects of activation and blockade of P2x receptors in the ventrolateral medulla on arterial pressure and sympathetic activity. J Auton Nerv Syst 76, 118-126.
43. Kanbar R, DePuy SD, West GH, Stornetta RL & Guyenet PG (2011). Regulation of visceral sympathetic tone by A5 noradrenergic neurons in rodents. J Physiol 589, 903-917.
44. Kang YM, He RL, Yang LM, Qin DN, Guggilam A, Elks C, Yan N, Guo Z & Francis J (2009). Brain tumour necrosis factor-α modulates neurotransmitters in hypothalamic paraventricular nucleus in heart failure. Cardiovasc Res 83, 737-746.
45. Kang YM, Zhang ZH, Xue B, Weiss RM & Felder RB (2008). Inhibition of brain proinflammatory cytokine synthesis reduces hypothalamic excitation in rats with ischemia-induced heart failure. Am J Physiol Heart Circ Physiol 295, H227-H236.
46. Kaplan JR, Manuck SB, Adams MR, Weingand KW & Clarkson TB (1987). Inhibition of coronary atherosclerosis by propranolol in behaviorally predisposed monkeys fed an atherogenic diet. Circulation 76, 1364-1372.
47. Karagiannis A, Sylantyev S, Hadjihambi A, Hosford PS, Kasparov S & Gourine AV (2015). Hemichannel-mediated release of lactate. J Cereb Blood Flow Metab DOI: 10.1177/0271678X15611912
48. Kasymov V, Larina O, Castaldo C, Marina N, Patrushev M, Kasparov S & Gourine AV (2013). Differential sensitivity of brainstem versus cortical astrocytes to changes in pH reveals functional regional specialization of astroglia. J Neurosci 33, 435-441.
49. Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A & Esler MD (1995). Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol 26, 1257-1263.
50. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A & Schwartz PJ (1998). Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 351, 478-484.
51. La Rovere MT, Pinna GD, Maestri R, Mortara A, Capomolla S, Febo O, Ferrari R, Franchini M, Gnemmi M, Opasich C, Riccardi PG, Traversi E & Cobelli F (2003). Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation 107, 565-570.
52. Leimbach WN Jr, Wallin BG, Victor RG, Aylward PE, Sundlof G & Mark AL (1986). Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation 73, 913-919.
53. Lioy DT, Garg SK, Monaghan CE, Raber J, Foust KD, Kaspar BK, Hirrlinger PG, Kirchhoff F, Bissonnette JM, Ballas N & Mandel G (2011). A role for glia in the progression of Rett's syndrome. Nature 475, 497-500.
54. Liu W, Tang Y & Feng J (2011). Cross talk between activation of microglia and astrocytes in pathological conditions in the central nervous system. Life Sci 89, 141-146.
55. Lown B & Verrier RL (1976). Neural activity and ventricular fibrillation. N Engl J Med 294, 1165-1170.
56. Madden CJ & Sved AF (2003). Cardiovascular regulation after destruction of the C1 cell group of the rostral ventrolateral medulla in rats. Am J Physiol Heart Circ Physiol 285, H2734-H2748.
57. Mansfield D, Kaye DM, Brunner La Rocca H, Solin P, Esler MD & Naughton MT (2003). Raised sympathetic nerve activity in heart failure and central sleep apnea is due to heart failure severity. Circulation 107, 1396-1400.
58. Marenholz I, Heizmann CW & Fritz G (2004). S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun 322, 1111-1122.
59. Marina N, Abdala AP, Korsak A, Simms AE, Allen AM, Paton JFR & Gourine AV (2011). Control of sympathetic vasomotor tone by catecholaminergic C1 neurones of the rostral ventrolateral medulla oblongata. Cardiovasc Res 91, 703-710.
60. Marina N, Ang R, Machhada A, Kasymov V, Karagiannis A, Hosford PS, Mosienko V, Teschemacher AG, Vihko P, Paton JFR, Kasparov S & Gourine AV (2015). Brainstem hypoxia contributes to the development of hypertension in the spontaneously hypertensive rat. Hypertension 65, 775-783.
61. Marina N, Tang F, Figueiredo M, Mastitskaya S, Kasimov V, Mohamed-Ali V, Roloff E, Teschemacher AG, Gourine AV & Kasparov S (2013). Purinergic signalling in the rostral ventro-lateral medulla controls sympathetic drive and contributes to the progression of heart failure following myocardial infarction in rats. Basic Res Cardiol 108, 317.
62. Mark AL (1990). Regulation of sympathetic nerve activity in mild human hypertension. J Hypertens 8 Suppl, S67-S75.
63. May CN, Yao ST, Booth LC & Ramchandra R (2013). Cardiac sympathoexcitation in heart failure. Auton Neurosci 175, 76-84.
64. Naughton MT, Benard DC, Liu PP, Rutherford R, Rankin F & Bradley TD (1995). Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 152, 473-479.
65. Okabe Y, Takahashi T, Mitsumasu C, Kosai K, Tanaka E & Matsuishi T (2012). Alterations of gene expression and glutamate clearance in astrocytes derived from an MeCP2-null mouse model of Rett syndrome. PLoS One 7, e35354.
66. Pascual O, Ben AS, Rostaing P, Triller A & Bessis A (2012). Microglia activation triggers astrocyte-mediated modulation of excitatory neurotransmission. Proc Natl Acad Sci USA 109, E197-E205.
67. Paton JFR & Waki H (2009). Is neurogenic hypertension related to vascular inflammation of the brainstem? Neurosci Biobehav Rev 33, 89-94.
68. Perea G, Navarrete M & Araque A (2009). Tripartite synapses: astrocytes process and control synaptic information. Trends Neurosci 32, 421-431.
69. 1-adrenoceptor activation. Circ Res 67, 1027-1034.
70. Potapenko ES, Biancardi VC, Zhou Y & Stern JE (2012). Altered astrocyte glutamate transporter regulation of hypothalamic neurosecretory neurons in heart failure rats. Am J Physiol Regul Integr Comp Physiol 303, R291-R300.
71. A-receptor crosstalk in hypothalamic neurosecretory neurons. J Neurosci 33, 631-640.
72. Ralevic V (2000). P2 receptors in the central and peripheral nervous systems modulating sympathetic vasomotor tone. J Auton Nerv Syst 81, 205-211.
73. Rana I, Stebbing M, Kompa A, Kelly DJ, Krum H & Badoer E (2010). Microglia activation in the hypothalamic PVN following myocardial infarction. Brain Res 1326, 96-104.
74. Rifai L, Winters J, Friedman E & Silver MA (2012). Initial description of cerebral oximetry measurement in heart failure patients. Congest Heart Fail 18, 85-90.
75. Rodbard S & Stone W (1955). Pressor mechanisms induced by intracranial compression. Circulation 12, 883-890.
76. Schultz HD, Li YL & Ding Y (2007). Arterial chemoreceptors and sympathetic nerve activity: implications for hypertension and heart failure. Hypertension 50, 6-13.
77. Schultz HD & Sun SY (2000). Chemoreflex function in heart failure. Heart Fail Rev 5, 45-56.
78. Shi P, Diez-Freire C, Jun JY, Qi Y, Katovich MJ, Li Q, Sriramula S, Francis J, Sumners C & Raizada MK (2010). Brain microglial cytokines in neurogenic hypertension. Hypertension 56, 297-303.
79. Shi P, Grobe JL, Desland FA, Zhou G, Shen XZ, Shan Z, Liu M, Raizada MK & Sumners C (2014). Direct pro-inflammatory effects of prorenin on microglia. PLoS One 9, e92937.
80. 1 adrenergic response. J Clin Invest 72, 732-738.
81. Siński M, Lewandowski J, Przybylski J, Bidiuk J, Abramczyk P, Ciarka A & Gaciong Z (2012). Tonic activity of carotid body chemoreceptors contributes to the increased sympathetic drive in essential hypertension. Hypertens Res 35, 487-491.
82. Sofroniew MV (2015). Astrogliosis. Cold Spring Harb Perspect Biol 7, a020420.
83. Spyer KM (1994). Annual review prize lecture. Central nervous mechanisms contributing to cardiovascular control. J Physiol 474, 1-19.
84. Strack AM, Sawyer WB, Hughes JH, Platt KB & Loewy AD (1989). A general pattern of CNS innervation of the sympathetic outflow demonstrated by transneuronal pseudorabies viral infections. Brain Res 491, 156-162.
85. Sun MK & Reis DJ (1994). Hypoxia selectively excites vasomotor neurons of rostral ventrolateral medulla in rats. Am J Physiol Regul Integr Comp Physiol 266, R245-R256.
86. Sun MK, Wahlestedt C & Reis DJ (1992). Action of externally applied ATP on rat reticulospinal vasomotor neurons. Eur J Pharmacol 224, 93-96.
87. Sun W, McConnell E, Pare JF, Xu Q, Chen M, Peng W, Lovatt D, Han X, Smith Y & Nedergaard M (2013). Glutamate-dependent neuroglial calcium signaling differs between young and adult brain. Science 339, 197-200.
88. Tang F, Lane S, Korsak A, Paton JFR, Gourine AV, Kasparov S & Teschemacher AG (2014). Lactate-mediated glia-neuronal signalling in the mammalian brain. Nat Commun 5, 3284.
89. Tomassoni D, Avola R, Di Tullio MA, Sabbatini M, Vitaioli L & Amenta F (2004). Increased expression of glial fibrillary acidic protein in the brain of spontaneously hypertensive rats. Clin Exp Hypertens 26, 335-350.
90. Trzebski A, Tafil M, Zoltowski M & Przybylski J (1982). Increased sensitivity of the arterial chemoreceptor drive in young men with mild hypertension. Cardiovasc Res 16, 163-172.
91. Vallbo AB, Hagbarth KE, Torebjörk HE & Wallin BG (1979). Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves. Physiol Rev 59, 919-957.
92. van de Borne P, Mark AL, Montano N, Mion D & Somers VK (1997). Effects of alcohol on sympathetic activity, hemodynamics, and chemoreflex sensitivity. Hypertension 29, 1278-1283.
93. Volterra A & Meldolesi J (2005). Astrocytes, from brain glue to communication elements: the revolution continues. Nat Rev Neurosci 6, 626-640.
94. Waki H, Gouraud SS, Maeda M & Paton JFR (2008). Gene expression profiles of major cytokines in the nucleus tractus solitarii of the spontaneously hypertensive rat. Auton Neurosci 142, 40-44.
95. Waki H, Liu B, Miyake M, Katahira K, Murphy D, Kasparov S & Paton JFR (2007). Junctional adhesion molecule-1 is upregulated in spontaneously hypertensive rats: evidence for a prohypertensive role within the brain stem. Hypertension 49, 1321-1327.
96. Wells JA, Christie IN, Hosford PS, Huckstepp RT, Angelova PR, Vihko P, Cork SC, Abramov AY, Teschemacher AG, Kasparov S, Lythgoe MF & Gourine AV (2015). A critical role for purinergic signalling in the mechanisms underlying generation of BOLD fMRI responses. J Neurosci 35, 5284-5292.
97. Xu H, Oliveira-Sales EB, McBride F, Liu B, Hewinson J, Toward M, Hendy EB, Graham D, Dominiczak AF, Giannotta M, Waki H, Ascione R, Paton JFR & Kasparov S (2012). Upregulation of junctional adhesion molecule-A is a putative prognostic marker of hypertension. Cardiovasc Res 96, 552-560.
98. Zoccal DB, Huidobro-Toro JP & Machado BH (2011). Chronic intermittent hypoxia augments sympatho-excitatory response to ATP but not to l-glutamate in the RVLM of rats. Auton Neurosci 165, 156-162.
99. Zubcevic J, Waki H, Raizada MK & Paton JFR (2011). Autonomic-immune-vascular interaction: an emerging concept for neurogenic hypertension. Hypertension 57, 1026-1033.